X-16124032-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_005314.3(GRPR):c.79G>A(p.Asp27Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000109 in 1,200,002 control chromosomes in the GnomAD database, including 1 homozygotes. There are 58 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005314.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GRPR | NM_005314.3 | c.79G>A | p.Asp27Asn | missense_variant | 1/3 | ENST00000380289.3 | NP_005305.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GRPR | ENST00000380289.3 | c.79G>A | p.Asp27Asn | missense_variant | 1/3 | 1 | NM_005314.3 | ENSP00000369643.2 |
Frequencies
GnomAD3 genomes AF: 0.000143 AC: 16AN: 111698Hom.: 0 Cov.: 23 AF XY: 0.000266 AC XY: 9AN XY: 33866
GnomAD3 exomes AF: 0.000126 AC: 23AN: 183082Hom.: 0 AF XY: 0.000192 AC XY: 13AN XY: 67588
GnomAD4 exome AF: 0.000106 AC: 115AN: 1088304Hom.: 1 Cov.: 28 AF XY: 0.000138 AC XY: 49AN XY: 354344
GnomAD4 genome AF: 0.000143 AC: 16AN: 111698Hom.: 0 Cov.: 23 AF XY: 0.000266 AC XY: 9AN XY: 33866
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 25, 2024 | The c.79G>A (p.D27N) alteration is located in exon 1 (coding exon 1) of the GRPR gene. This alteration results from a G to A substitution at nucleotide position 79, causing the aspartic acid (D) at amino acid position 27 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at